The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Zykov V.P.

Russian Medical Academy Continuing Professional Education

Komarova I.B.

Russian Medical Academy Continuing Professional Education

Development of speech disorders in children

Authors:

Zykov V.P., Komarova I.B.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(11): 106‑110

DOI: 10.17116/jnevro2021121111106

Read: 5958 times

Download PDF (RU)
Contact the author
Table of contents

DEVELOPMENT OF SPEECH DISORDERS IN CHILDREN
DEVELOPMENT OF SPEECH DISORDERS IN CHILDREN

To cite this article:

Zykov VP, Komarova IB. Development of speech disorders in children. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(11):106‑110. (In Russ.)
https://doi.org/10.17116/jnevro2021121111106

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Pote­ntial of animal-derived neuropeptides in complex therapy of diabetic neuropathy in patients with type 2 diabetes mellitus. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):83-87
The possibility of using neurotropic therapy in patients with persistent postural-perceptual dizziness. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):89-94
Proinflammatory cyto­kines — as a marker of the effe­ctiveness of neuroprotection in children with peri­natal nervous system damage. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):62-66
Targets of rational neuroprotection in the therapy of chro­nic cere­bral ischemia and the possibilities of achieving them. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):96-101
Therapeutic equivalence of intravenous and intramuscular dosage forms of Cortexin in ischemic stro­kes. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(12):60-67
Problematic inte­rnet use by children with atte­ntion defi­cit hype­ractivity diso­rder. S.S. Korsakov Journal of Neurology and Psychiatry. 2026;(1):69-76
Effi­cacy and safety of Cortexin as addi­tional therapy in patients with depressive diso­rder. S.S. Korsakov Journal of Neurology and Psychiatry. 2026;(2):92-96
The effect of neuroprotectors on the level of BDNF, tumor necrosis factor alpha and apoptosis markers, and in acute cere­brovascular acci­dents. S.S. Korsakov Journal of Neurology and Psychiatry. 2026;(2):123-129
Abstract:

The function of the formation of speech skills is decisive in the development of a child in communication and assimilation of information. Early pediatric diagnosis should become a routine practice of monitoring children from infancy to school age for the timely correction of speech disorders and associated dysgraphia and dyslexia. According to the ICD-10 classification, speech developmental disorders are divided into the following options: articulation impairment, delay in expressive and impressive speech. Articulation disorders, stuttering, impaired expressive speech are the most common and most favorable prognosis for speech therapy interventions. The data on the effectiveness of disorders of the receptive (impressive) language are ambiguous, since there is a high likelihood of a combination with neurogenetic diseases and autism. The development of speech therapy programs will make it possible to broader coverage of those in need of treatment, including complex course therapy with neuropeptides (cortexin).

Keywords:

developmental disorders of speech
impaired articulation
stuttering
impaired expressive and impressive speech
Cortexin

Authors:

Zykov V.P.

Russian Medical Academy Continuing Professional Education

Komarova I.B.

Russian Medical Academy Continuing Professional Education

Received:

30.08.2021

Accepted:

14.09.2021

Close metadata

References:

  1. Burden V, Stott CM, Forge J, Goodyer I. The Cambridge Language and Speech Project (CLASP). I. Detection of language difficulties at 36 to 39 months. Dev Med Child Neurol. 1996;38(7):613-631. 
  2. Norbury CF, Gooch D, Wray C, Baird G, Charman T, Simonoff E, Vamvakas G, Pickles A. The impact of nonverbal ability on prevalence and clinical presentation of language disorder: evidence from a population study. J Child Psychol Psychiatry. 2016;57(11):1247-1257. https://doi.org/10.1111/jcpp.12573
  3. Brownlie EB, Beitchman JH, Escobar M, Young A, Atkinson L, Johnson C, Wilson B, Douglas L. Early language impairment and young adult delinquent and aggressive behavior. J Abnorm Child Psychol. 2004;32(4):453-467. PMID: 15305549. https://doi.org/10.1023/b:jacp.0000030297.91759.74
  4. Powell RK. Unique Contribution to the Curriculum: From Research to Practice for Speech Therapists in Schools. Lang Speech Hear Serv Sch. 2018;49(2):140-147.  https://doi.org/10.1044/2017_LSHSS-17-0059
  5. Karla K. McGregor. How We Fail Children With Developmental Language Disorder Language, Speech, and Hearing Services in Schools Clinical Focus2 Oct. 2020;51(4):981-992.  https://doi.org/10.1044/2020_LSHSS-20-00003
  6. Classification of mental and behavioral disorders: ICD-10/USD-10: Clinical. descriptions and guidelines for diagnosis/WHO. Per. in rus. lang. ed. Nuller Yu.L., Tsirkin S.Yu. SPb.: Overlaid; 1994. (In Russ.).
  7. Grigorova E, Ristovska G, Jordanova NP. Pril (Makedon Akad Nauk Umet Odd Med Nauki) Prevalence of Phonological Articulation Disorders in Preschool Children in the City of Skopje. 2020;41(3):31-37.  https://doi.org/10.2478/prilozi-2020-0043
  8. Skvortsov IA, Adashinskaya GA, Nefedova IV. Modified method of neuropsychological diagnostics and correction in developmental disorders of higher mental functions in children. Teaching manual. M.: Trivola; 2000. (In Russ.).
  9. Wiesel TG. Fundamentals of Neuropsychology. M.: ACE. Transitbook; 2006. (In Russ.).
  10. Sander RW, Osborne CA. Stuttering: Understanding and Treating General Disabilities. Am Fam Doctor. 2019;100(9):556-560. PMID: 31674746.
  11. Kraft SJ, Yairi E. Genetic bases of stuttering: the state of the art. Folia Phoniatr Logop. 2012;64(1):34-47.  https://doi.org/10.1159/000331073
  12. Raza MH, Riazuddin S, Drayna D. Identification of an autosomal recessive stuttering locus on chromosome 3q13.2-3q13.33. Hum Genet. 2010;128(4):461-463.  https://doi.org/10.1007/s00439-010-0871-y
  13. Chang S, Guenther FH. Involvement of the Cortico-Basal Ganglia-Thalamocortical Loop in Developmental Stuttering. Front Psychol. 2020;10:3088. eCollection 2019. https://doi.org/10.3389/fpsyg.2019.03088
  14. Craig-McQuaide A, Akram H, Zrinzo L, Tripoliti E. A review of brain circuitries involved in stuttering. Front Hum Neurosci. 2014;8:884. eCollection 2014. https://doi.org/10.3389/fnhum.2014.00884
  15. Harrewijn A, Schel MA, Boelens H, Nater CM, Haggard P, Crone EA. Children who stutter show reduced action-related activity in the rostral cingulate zone. Neuropsychologia. 2017;96:213-221.  https://doi.org/10.1016/j.neuropsychologia.2017.01.022
  16. Chang SE. Research updates in neuroimaging studies of children who stutter. Semin Speech Lang. 2014;35(2):67-79.  https://doi.org/10.1055/s-0034-1382151
  17. Kikano GE. Stuttering: An Overview. Am Fam Physician. 2008;77(9):1271-1276.
  18. Yairi E, Ambrose NG. Early childhood stuttering I: persistency and recovery rates. J Speech Lang Hear Res. 1999;42(5):1097-1112. https://doi.org/10.1044/jslhr.4205.1097
  19. Paden EP, Yairi E, Ambrose NG. Speech Early childhood stuttering II: initial status of phonological abilities. J Speech Lang Hear Res. 1999;42(5):1113-1124. https://doi.org/10.1044/jslhr.4205.1113
  20. Tim Saltuklaroglu, Joseph Kalinowski, Vijaya K Guntupalli Towards a common neural substrate in the immediate and effective inhibition of stuttering. Int J Neurosci. 2004;114(4):435-450.  https://doi.org/10.1080/00207450490422687
  21. Maguire GA, Riley G DI, Franklin DL, Gottschalk LA. Risperidone for the treatment of stuttering. J Clin Psychopharmacol. 2000;20(4):479-482.  https://doi.org/10.1097/00004714-200008000-00013
  22. Blumenfeld A, Olalla JC, Angelo SID, González NS, Yael Sadras, Graizer S, Macario A, Salamanco G. Language development delay in 24-month-old children at a health care center of the City of Buenos Aires. Arch Argent Pediatr. 2018;116(4):242-247.  https://doi.org/10.5546/aap.2018.eng.242
  23. Zengin-Akkuş P, Çelen-Yoldaş T, Kurtipek G, Özmert EN. Speech delay in toddlers: Are they only «late talkers»? Turk J Pediatr. 2018;60(2):165-172.  https://doi.org/10.24953/turkjped.2018.02.008
  24. Schum RL. Language screening in the pediatric office setting. Pediatr Clin North Am. 2007;54(3):425-436, v.  https://doi.org/10.1016/j.pcl.2007.02.010
  25. Morgan A, Fisher SE, Scheffer I, Hildebrand M, Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean L JH, Mirzaa G, Amemiya A, editors. FOXP2-Related Speech and Language Disorders. In: GeneReviews [Internet]. Seattle (WA): University of Washington, Seattle; 1993—2021. 2016 Jun 23 [updated 2017 Feb 2]. PMID: 27336128. Bookshelf ID: NBK368474.
  26. Konopka G, Bomar JM, Winden K, Coppola G, O Jonsson ZO, Gao F, Peng S, Preuss TM, Wohlschlegel JA, Geschwind DH. Human-specific transcriptional regulation of CNS development genes by FOXP2. Nature. 2009;462(7270):213-217.  https://doi.org/10.1038/nature08549
  27. Brenda M, Finucane BM, David H, Ledbetter DH, Vorstman J AS. Diagnostic genetic testing for neurodevelopmental psychiatric disorders: Closing the gap between recommendation and clinical implementation mCurr Opin. Genet Dev. 2021;68:1-8. Published online 2021 Jan 9.  https://doi.org/10.1016/j.gde.2020.12.016
  28. Law J, Garrett Z, Nye C. Speech and language therapy interventions for children with primary speech and language delay or disorder. Cochrane Database Syst Rev. 2003;3:CD004110. https://doi.org/10.1002/14651858.CD004110
  29. Chutko LS, Yeletskaya OV (edited by). Speech disorders in children. M. 2019. (In Russ.).
  30. Zykov VP, Serebrennikova EB, Panchenko TN, Sycheva YaB, Presnyakova SN, Mazur EL, Salova MN, Golubeva ES. Korsakov Journal of Neurology and Psychiatry. 2018;118:3:27-31. (In Russ.). https://doi.org/10.17116/jnevro20181183127-31
  31. Zavadenko NN, Davydova LA, Suvorinova NYu, Khondkaryan GSh. Potential of peptidergic nootropic therapy in developmental dysphasia in children. Zh Nevrol Psikhiatr im. S.S. Korsakova. 2019;119(11):47-53. (In Russ.). https://doi.org/10.17116/jnevro201911911147
  32. Gulyaeva NV. Molecular mechanisms of brain peptide-containing drugs: cortexin. Zh Nevrol Psychiatrist named after S.S. Korsakov. 2018;118(10):93-96. (In Russ.). https://doi.org/10.17116/jnevro201811810193
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.